Tirzepatide for Weight Loss
Vital IV Infusions Offers Tirzepatide for Weight Loss Treatment in Chatham, NJ
Roughly two out of three U.S. adults are overweight or obese (69 percent) and one out of three are obese (36 percent). (Harvard School of Public Health)
Tirzepatide, is a groundbreaking medication that helps manage type-2 diabetes and promotes weight loss simultaneously. By mimicking the feeling of fullness and slowing down digestion, Tirzepatide reduces calorie intake, leading to significant weight loss. It’s proven to be more effective than other medications in promoting weight loss. Recently FDA-approved for off-label use in weight loss, Tirzepatide opens up new possibilities for those struggling with obesity and related conditions. Experience a healthier lifestyle with Vital IV – your path to better health!
If you live in the Chatham, NJ, area and are looking for an alternative treatment for your weight loss journey, Vital IV can help. Contact us today and schedule your consultation.
What is Tirzepatide and how does it help with Weight Loss?
Tirzepatide, is a groundbreaking medication that acts as a dual agonist for the two primary human GLP-1 (glucagon-like peptide 1 receptor agonists) and GIP (glucagon-like peptide) incretins. This unique mechanism of action offers impressive glycemic efficacy while also leading to weight loss. By mimicking the sensation of being full, Tirzepatide helps reduce caloric intake and delays gastric emptying by decreasing glucagon secretion in a glucose-dependent manner. What sets Tirzepatide apart is its remarkable effectiveness in promoting significant body weight loss, as demonstrated in phase 3 trials involving patients with type-2 diabetes. Compared to current drugs like semaglutide and insulin degludec, Tirzepatide exhibits superior therapeutic efficacy. Recently approved by the FDA for off-label use in weight loss purposes, Tirzepatide has opened up new possibilities for individuals struggling with obesity and related conditions. With its ability to address both glycemic control and promote healthy weight management, this medication represents a promising development in diabetes treatment options
How does Tirzepatide work?
Tirzepatide has a unique function that helps individuals feel fuller for longer periods of time, which ultimately leads to a decrease in calorie intake. This is achieved by delaying gastric emptying through the reduction of glucagon secretion in response to glucose levels. By slowing down the process of gastric emptying, Tirzepatide effectively curbs appetite, enhances eating control, and diminishes food cravings.
At Vital IV Infusions, we offer a variety of options for weight loss treatment in Chatham, NJ.
Are you a candidate for Tirzepatide?
There are two qualifications for Tirzepatide:
- A BMI over 30 and no weight-related complications
- A BMI over 27 with weight-related complications
Why is the weight loss goal 10%? What if I want to lose more weight?
Extensive clinical research has demonstrated that a weight loss goal of 10% is both achievable and highly beneficial for individuals seeking to improve their overall health. This target can be reached through the combination of an FDA-approved metabolic medication and accountability coaching. While many patients may surpass this milestone, 10% serves as the fundamental benchmark due to its ability to yield significant improvements in various metabolic and inflammatory markers. Importantly, losing 10% of body weight has been proven to effectively reduce multiple risk factors associated with cardiovascular disease, such as high blood pressure, high cholesterol levels, and diabetes. Additionally, this level of weight loss has shown positive outcomes in alleviating symptoms related to depression, arthritis, and sleep apnea while enhancing overall quality of life. Numerous studies have substantiated the attainability of a 10% body weight reduction for most people by considering biological influences as well as genetic and environmental factors.
What will my food goals be?
Developing a sustainable and adaptable approach to nutrition involves making conscious choices that prioritize the inclusion of protein, fiber, and healthy fats while minimizing the consumption of fast-digesting carbs. This approach aims to promote overall health without the need for strict calorie counting or restrictive eating habits.
Treatment Suggestions:
When taking Tirzepatide, it is important to follow some dietary recommendations. These include consuming a diet rich in fiber, with an emphasis on fruits and vegetables that are high in this nutrient. It is also advisable to have small meals that are high in protein, as the medication can slow down digestion. Avoiding foods that are high in fat is recommended since they take longer to digest. Additionally, it is best to limit alcohol intake to occasional occasions and ensure a daily intake of at least 32 ounces of water to prevent constipation. Following these guidelines will help optimize the effects of Tirzepatide while maintaining a healthy diet and lifestyle.
Is the medication safe?
GLP-1s and GIP incretins are FDA-approved dual agents and safe. They are generally very well tolerated, with minimal side effects.
Can I take additional weight loss medication, in addition to GLP-1/ GIP incretins?
We do not recommend taking any weight loss medication that is not a GLP-1/ GIP incretin during your weight loss program.
Contraindications:
There are rare situations where Tirzepatide is contraindicated. Patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Does Tirzepatide have side effects?
Most common side effects are: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, and heartburn. Note that most of these are manageable by proper dosing and some overlap with the intended effect of “feeling full”.
- Getting the Inside Dope on Ketamine’s Mysterious Ability to Rapidly Relieve Depression – Scientific American (March 2018)
- Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study – Journal of Child and Adolescent Psychopharmacology (July 2018)
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression – American Journal of Psychiatry (Dec 2017)
- World-First Ketamine Trial Shows Promise For Geriatric Depression – American Journal of Geriatric Psychiatry (July 2017)
- FDA Data Support Ketamine as Depression Therapy – MedPage Today (May 2017)
- How Ketamine Infusion Will Transform the Way Depression is Treated – The Doctor Weighs In (July 2017)
- Club Drug Ketamine Gains Traction As A Treatment For Depression – NPR.org (Sept 2015)
- Ketamine may be quick, effective treatment for untreatable depression – CBS News (May 2013)
- The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review – National Center for Biotechnology Information (Sept 2014)
